These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20332442)

  • 1. Tumor-specific correlation of tumor M2 pyruvate kinase in pre-invasive, invasive and recurrent cervical cancer.
    Landt S; Jeschke S; Koeninger A; Thomas A; Heusner T; Korlach S; Ulm K; Schmidt P; Blohmer JU; Lichtenegger W; Sehouli J; Kuemmel S
    Anticancer Res; 2010 Feb; 30(2):375-81. PubMed ID: 20332442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma.
    Kaura B; Bagga R; Patel FD
    J Obstet Gynaecol Res; 2004 Jun; 30(3):193-6. PubMed ID: 15210041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor M2 pyruvate kinase in plasma of patients with urological tumors.
    Roigas J; Schulze G; Raytarowski S; Jung K; Schnorr D; Loening SA
    Tumour Biol; 2001; 22(5):282-5. PubMed ID: 11553857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of angiogenin (ANG) in invasive cervical cancer and in cervical intraepithelial neoplasia (CIN).
    Bodner-Adler B; Hefler L; Bodner K; Leodolter S; Frischmuth K; Kainz C; Mayerhofer K
    Anticancer Res; 2001; 21(1B):809-12. PubMed ID: 11299848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor M2 pyruvate kinase in renal cell carcinoma. Studies of plasma in patients].
    Roigas J; Schulze G; Raytarowski S; Jung K; Schnorr D; Loening SA
    Urologe A; 2000 Nov; 39(6):554-6. PubMed ID: 11138278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of plasmatic tumor M2 pyruvate kinase and carcinoembryonic antigen in the survival of colorectal cancer patients.
    Fatela-Cantillo D; Fernandez-Suarez A; Moreno MA; Gutierrez JJ; Iglesias JM
    Tumour Biol; 2012 Jun; 33(3):825-32. PubMed ID: 22231432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers.
    Sidorkiewicz I; Zbucka-Krętowska M; Zaręba K; Lubowicka E; Zajkowska M; Szmitkowski M; Gacuta E; Ławicki S
    BMC Cancer; 2019 Apr; 19(1):398. PubMed ID: 31035945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum CYFRA 21-1 assay in squamous cell carcinoma of the cervix.
    Ferdeghini M; Gadducci A; Annicchiarico C; Prontera C; Malagnino G; Castellani C; Facchini V; Bianchi R
    Anticancer Res; 1993; 13(5C):1841-4. PubMed ID: 7505543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The significance of TU M2-PK tumor marker for lung cancer diagnostics].
    Oremek G; Kukshaĭte R; Sapoutzis N; Ziolkowski P
    Klin Med (Mosk); 2007; 85(7):56-8. PubMed ID: 17882813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating vascular endothelial growth factors and their soluble receptors in pre-invasive, invasive and recurrent cervical cancer.
    Kuemmel S; Thomas A; Landt S; Fuger A; Schmid P; Kriner M; Blohmer JU; Sehouli J; Schaller G; Lichtenegger W; Köninger A; Fuchs I
    Anticancer Res; 2009 Feb; 29(2):641-5. PubMed ID: 19331214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of heat shock protein 90
    Han S; Cheng Z; Zhao X; Huang Y
    J Int Med Res; 2019 Nov; 47(11):5518-5525. PubMed ID: 31426690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer.
    Ventrucci M; Cipolla A; Racchini C; Casadei R; Simoni P; Gullo L
    Dig Dis Sci; 2004 Aug; 49(7-8):1149-55. PubMed ID: 15387337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of tumor M2-pyruvate kinase should not be used as a tumor marker for hematological malignancies and solid tumors.
    Staib P; Hoffmann M; Schinköthe T
    Clin Chem Lab Med; 2006; 44(1):28-31. PubMed ID: 16375581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma.
    Oremek GM; Teigelkamp S; Kramer W; Eigenbrodt E; Usadel KH
    Anticancer Res; 1999; 19(4A):2599-601. PubMed ID: 10470201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels and diagnostic utility of macrophage-colony stimulating factor, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 as tumor markers in cervical cancer patients.
    Zajkowska M; Zbucka-Krętowska M; Sidorkiewicz I; Lubowicka E; Gacuta E; Szmitkowski M; Chrostek L; Ławicki S
    Tumour Biol; 2018 Jul; 40(7):1010428318790363. PubMed ID: 30052166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
    Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
    Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous cell carcinoma antigen and cancer antigen 125 in southern Indian cervical cancer patients.
    Porika M; Vemunoori AK; Tippani R; Mohammad A; Bollam SR; Abbagani S
    Asian Pac J Cancer Prev; 2010; 11(6):1745-7. PubMed ID: 21338226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected].
    Mathur SP; Mathur RS; Gray EA; Lane D; Underwood PG; Kohler M; Creasman WT
    Gynecol Oncol; 2005 Sep; 98(3):467-83. PubMed ID: 15982726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels.
    Sheng X; Du X; Zhang X; Li D; Lu C; Li Q; Ma Z; Song Q; Wang C
    Croat Med J; 2009 Oct; 50(5):455-64. PubMed ID: 19839069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of post-radiation serum squamous cell carcinoma antigen and primary tumor regression for cervical squamous cell carcinoma.
    Wan Q; Yan W; Liu Y; Lin Y; Lu Z
    Cancer Biomark; 2020; 29(3):327-335. PubMed ID: 32716344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.